VaramirStart free · no cardSign in
RGNX as of Oct 31 · 15:28 ET
RGNXNasdaqBiological Products, (No Diagnostic Substances)

Regenxbio Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±21.6%
avg realized
±10.2%
Nov 6 '24±17.3%▲+18.66%×1.08
Mar 13 '25±17.6%▲+2.60%×0.15
May 12 '25±10.8%▲+2.63%×0.24
Aug 7 '25±17.3%▼−4.01%×0.23
Q3 FY25±16.9%▼−3.79%×0.22
Q1 FY26±42.1%▼−4.60%×0.11
May 14 '26±32.5%▼−37.80%×1.16
Q2 FY26±18.2%▲+7.43%×0.41
quarterimplied−45%0+45%realized×
Q2 FY26±18.2%▲+7.43%×0.41
May '26±32.5%▼−37.80%×1.16
Q1 FY26±42.1%▼−4.60%×0.11
Q3 FY25±16.9%▼−3.79%×0.22
Aug '25±17.3%▼−4.01%×0.23
May '25±10.8%▲+2.63%×0.24
2 older reports
Mar '25±17.6%▲+2.60%×0.15
Nov '24±17.3%▲+18.66%×1.08
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

4tracked funds holding RGNXN-PORT · Aug 31 '26
2customers disclosing RGNX as a supplierSEC filings

Bear2

6 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
24managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

RGNX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±70.8% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.